Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) to Post FY2027 Earnings of $1.01 Per Share, Wedbush Forecasts
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Equities research analysts at Wedbush decreased their FY2027 EPS estimates for Ultragenyx Pharmaceutical in a research report issued on Friday, August 2nd. Wedbush analyst L. Chico now expects that the biopharmaceutical company will earn $1.01 per share for the year, down from their prior estimate of $1.04. […]
More Stories
Ice Age 6: Boiling Point- Release Date, Voice Artist, and Synopsis
Hello, Ice Age fans! Your favourite animated animal movie is returning to the US theaters. Ice Age 6, or Ice...
I Will Find You: Sam Worthington’s Upcoming Series
Netflix is coming up with an all-new miniseries featuring the famous Sam Worthington as Jake Sully from the 2009 film...
Big Mistakes Season 2: Release Date, Cast, and Synopsis
Netflix’s hit comedy-thriller series, Big Mistakes, got an official renewal. The dark comedy series is bringing back the humor of...
Top 11 E-Commerce Companies in the USA for Your Convenience
There are a huge number of e-commerce companies in the USA. These companies are growing exponentially with the increasing demand....
Strip Law Season 2 Renewed? Check out the Renewal Status
Netflix is cancelling one series after another, and Strip Law, the American adult animated sitcom, is among them. Netflix has...
Netflix’s Upcoming Drama, Husbands in Action, is Releasing Soon
Are you also a Korean drama lover? If yes, Good news! An all-new comedy drama is arriving soon on Netflix....